SynthesisBMC cancer2024

Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta-analysis.

Amjad Zafar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.